Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pain 1Lymphoid Interstitial Pneumonia 1Hot Flashes 1Chronic Disease 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Platinum 2Gemcitabine 2Gefitinib 2Cisplatin 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1temsirolimus 1linrodostat 1ficlatuzumab 1durvalumab 1cediranib 1adavosertib 1Trioxsalen 1Soybean Proteins 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Phototherapy 1Photochemotherapy 1Pemetrexed 1Paclitaxel 1Nivolumab 1Immunohistochemistry 1Dihematoporphyrin Ether 1Carboplatin 1Biopsy 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoid Interstitial Pneumonia × Soybean Proteins × Clear all
NCT02007200 2016-10-24

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery

National Cancer Institute (NCI)

Phase 2 Completed
55 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡